Asahi Life Asset Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Asahi Life Asset Management Co., Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $204,910 - $225,490	227 New	227 $218,000
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $56,002 - $66,428	-80 Reduced 12.5%	560 $402,000
Q1 2023 May 01, 2023	BUY	$680.49 - $826.97 $435,513 - $529,260	640 New	640 $525,000
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $345,460 - $465,469	-630 Reduced 75.9%	200 $118,000
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $493,949 - $579,696	830 New	830 $580,000
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $608,471 - $721,817	-1,060 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $73,284 - $86,573	155 Added 17.13%	1,060 $592,000
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $67,009 - $82,230	-150 Reduced 14.22%	905 $428,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $504,606 - $641,418	1,055 New	1,055 $510,000
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $370,075 - $508,288	-1,350 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $369,171 - $429,826	1,350 New	1,350 $374,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.